Specificity: GPR27 siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: GPR27 shRNA Plasmid (Mouse) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: GPR27 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: GPR27 siRNA (Rat) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: GPR27 shRNA Plasmid (Rat) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: GPR27 shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: GPR173 siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: GPR85 siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: GPR173 shRNA Plasmid (Mouse) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: GPR85 shRNA Plasmid (Mouse) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: GPR173 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: GPR85 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: GPR173 siRNA (Rat) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: GPR173 shRNA Plasmid (Rat) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: GPR173 shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: GPR85 shRNA Plasmid (Human) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
Specificity: GPR85 siRNA (Rat) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression. Purity: > 97% Form: Lyophilized
Specificity: GPR85 shRNA Plasmid (Rat) contains 3 different target-specific plasmids each encoding 19-23 nt (plus hairpin) shRNAs designed to knock down gene expression. Each plasmid contains a resistance gene for the selection of cells stably expressing shRNA. Form: Lyophilized
We use cookies necessary for the function of our website, to improve your experience, analyse our traffic, and cookies that optimise the performance. To learn more about our cookies, please read our Cookie Notice.